Best Life Sciences Companies in Santa Monica, United States
The 35 best Life Sciences companies in Santa Monica, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Opiant Pharmaceuticals.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Santa Monica
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Opiant Pharmaceuticals Developer of therapeutics for the treatment of addictive and eating disorders | $65M | 49 mo ago | Acquired | — | 2005 | — | — | — |
| 2 | Imagen Biopharma Precision biologic therapeutics for immuno-oncology, autoimmunity, and other diseases | $10M | 135 mo ago | Series A | Rodolfo Chaparro Co-Founder and Head of Immunology | 2014 | — | — | — |
| 3 | Islet Sciences US-based, early-stage biopharma developing interleukin 12 inhibitors for Diabetes treatment | $8M | 128 mo ago | Public | Gary Blackburn CEO & President | 2010 | — | — | — |
| 4 | Century Health AI-powered health tech company accelerating access to breakthrough treatments 45Funding top 35%Talent top 38%AI top 45%Market bottom 37% All 5 signals ▾Fundingtop 35% Talenttop 38% AItop 45% Marketbottom 37% Globalbottom 29% Funding: Raised $7.0M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $7M | 4 mo ago | Seed | Vish Srivastava Co-Founder & CEO | 2023 | — | — | — |
| 5 | Auritec Pharma Drug delivery company focused on women’s health. | $6M | 158 mo ago | Funding Raised | Tom Smith Founder & CEO | 2002 | — | — | — |
| 6 | Citruslabs Provider of an online patient recruitment platform for clinical trials | $5M | 87 mo ago | Series A | Rogelio Arellano Software Engineer & Co-Founder | 2015 | Cart FunctionalityWix eCommerceWix+28 | — | 1 launch |
| 7 | Knee Voice Developer of the device for tracking the health of the knee | $2M | 25 mo ago | Seed | Carlos Leal Co - Founder | 2015 | — | — | — |
| 8 | Doctor Evidence Evidence based medical decision solutions for multiple healthcare stakeholders | $2M | 186 mo ago | Acquired | — | 2004 | — | — | — |
| 9 | Brinter Provider of 3D bioprinting solutions and services | $1M | 63 mo ago | Seed | Tomi Kalpio Co-Founder & CEO | 2018 | WordPressMySQLPHP+24 | — | — |
| 10 | General Nanotherapeutics Developer of nanoparticles for long-term remission of immune-mediated disorders | $300K | 50 mo ago | Funding Raised | David Horwitz CEO | 2018 | — | 6 patents Peptide-based therapeutics targeting immune-mediated diseases | — |
Top 10 Life Sciences companies in Santa Monica
#1
Seed · Santa Monica, California · founded 2023$7Mraised▾
AI-powered health tech company accelerating access to breakthrough treatments. It accelerates drug development and commercialization by applying AI to real-world data and analyzes data to provide insights.
- May 2026Seed$5M
- Mar 2024Seed$2M
#2
Acquired · Santa Monica, California · founded 2005 · 31 employees$65.2Mraised▾
Developer of therapeutics for the treatment of addictive and eating disorders. The lead drug is NARCAN Nasal Spray for the treatment of opioid overdose. Also developing a treatment for binge eating disorder, and a treatment for cocaine use disorder.
- Aug 2022Grant (prize money)$7.4M
- Dec 2020Post IPO$50M
- Jan 2018Post IPO$5.3M
- Mar 2016Post IPO$2.5M
#3
Seed · Santa Monica, California · founded 2015 · 7 employees$1.9Mraised▾
Developer of the device for tracking the health of the knee. The knee voice device is worn around the knee which used signals and telemetry to detect tissue and joint condition. This device can be used while running, sports, exercise, and other physical activities. The device is used with an application that records the data and helps in preventing knee damage.
- Aug 2024Seed$1.2M
- Mar 2023Seed$20K
- Mar 2021Seed$604.9K
#4
Public · Santa Monica, California · founded 2010 · 5 employees$7.6Mraised▾
Islet Sciences is a US-based, early-stage biopharma developing interleukin 12 inhibitors for Diabetes treatment. Company’s current pipeline includes immune modulating small molecule interleukin 12 inhibitors for the disorders associated with inflammation. IL-12 and STAT 4 activation are important pathways linked to inflammatory damage to insulin producing cells. The company has identified 3 compounds being developed in preclinical studies as orally bioavailable immune modulators. The company is also developing a cell therapy based artificial pancreas for the treatment of type 1 diabetes, and a PCR-based molecular diagnostic measuring hypomethylated beta cell-derived DNA as a biomarker of beta cell loss for the early detection of the onset of type 1 diabetes or insulin dependent type 2 diabetes.
- Dec 2015Series A$30K
- Apr 2014Series A$2.2M
- May 2012Series A$4.2M
- Oct 2011Seed$1.1M
#5
Series A · Santa Monica, California · founded 2014$10Mraised▾
Imagen engaged in the development of precision therapeutics for a broad range of human diseases. Imagen’s therapeutic and discovery technologies capture the principal advantages of T cell-based immunotherapies while addressing many of the limitations and toxicities seen in the current immunotherapeutics landscape. The company's technology and research programs are undisclosed.
- Jun 2015Series A$10M
#6
Funding Raised · Santa Monica, California · founded 2002 · 7 employees$6.2Mraised▾
Auritec Pharmaceutical is a drug delivery company focused on women’s health. Its main product is an intravaginal ring (IVR) sustained release drug delivery system: VersaRing™. It has a large pipeline of programs in clinical and preclinical stage ranging from HIV, herpes, diabetes, to uterine fibroids, endometriosis, and many more. Versa is a technology platform for drug delivery that can deliver a broad range of drugs:-It focusses on FDA approved drugs used for the management of chronic conditions, that have large markets, and that have high potential to achieve therapeutic levels via vaginal delivery. Since its inception, Auritec has received over $20 million in NIH funding to develop sustained-release formulation for a number of serious or life-threatening diseases.
- May 2012Grant (prize money)$300K
- Feb 2012Grant (prize money)$296.4K
- Jul 2011Grant (prize money)$3M
- Jun 2010Grant (prize money)$1.1M
#7
Series A · Santa Monica, California · founded 2015 · 17 employees$4.6Mraised▾
Provider of an online patient recruitment platform for clinical trials. The platform tracks the patients based on the mobile app and health analytics and selects the best suitable candidate for medical research. The selected candidates sign up for the trial and the dashboard provides features as contacting, scheduling, organizing, and pre-screening candidates.
- May 2019Series A$2.6M
- Jan 2018Seed$2M
- Sep 2016Seed—
- Jun 2016Seed—
#8
Seed · Santa Monica, California · founded 2018 · 15 employees$1.5Mraised▾
Brinter is the bioprinting branch of a Finnish 3D printing company providing 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries. It provides Brinter 1 modular bioprinter and th automatic dispenser head change tool. The company clients and partners are Nokia, ABB, Carbodeon, Green lab, Vertech, and many others.
- Jun 2021Seed$1.5M
#9
Acquired · Santa Monica, California · founded 2004 · 55 employees$1.5Mraised▾
Doctor Evidence (DRE) is a health technology and consulting company that utilizes state-of-the-art solutions to identify, synthesize, and analyze complex clinical research data into fit-to-purpose actionable knowledge. It offers an integrated evidence-based-medicine (EBM) suite of solutions for finding and analyzing data in published studies, epidemiological and drug label datasets. It uses a Digital Outcome Conversion (DOC) approach of taking data from static sources and to transform it into reusable, dynamic databases. Its product portfolio includes DOC Library, a solution to organize literature in an online portal; DOC Data, to manage and analyze data from clinical studies; DOC Create, to build and export deliverables within an online, collaborative workspace; DOC Label, to search, compare and highlight keywords and phrases in FDA and UK labeling for all FDA and MHRA approved products; DOC NHANES, to enable browser-based access and in-depth analysis of the content of the Center for Disease Control’s National Health and Nutrition Examination Survey (NHANES) and GROWTH, to communicate evidence-backed value for the purpose of shaping high-level corporate strategy. The company serve
- Mar 2011Seed$1.5M
#10
Funding Raised · Santa Monica, California · founded 2018$300Kraised▾
Developer of nanoparticles for long-term remission of immune-mediated disorders. These proprietary nanoparticles target specific immune cells, reprogramming them to reverse and prevent immune-mediated diseases. In active disease, the nanoparticles target immune cells in lymphoid tissue, restoring their ability to silence disease-causing cells and terminating disease activity. In susceptible individuals, the nanoparticles induce protective immune cells to prevent disease onset. The high local concentration of therapeutic agents enhances efficacy while reducing adverse effects and cost. The nanoparticles are formulated to attach to specific T cells, inducing the proliferation of regulatory T cells and restoring immune system balance to maintain disease remission.
- Jul 2022Grant (prize money)$300K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.